T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-gamma that can be further increased by a novel protein kinase C agonist PEP005.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples